Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 69

1.

Coexistence of acute takotsubo syndrome and acute coronary syndrome.

Sharkey SW, Kalra A, Henry TD, Smith TD, Pink VR, Lesser JR, Garberich RF, Maron MS, Maron BJ.

Catheter Cardiovasc Interv. 2019 Nov 6. doi: 10.1002/ccd.28595. [Epub ahead of print]

PMID:
31696663
2.

Revascularization in Patients With Spontaneous Coronary Artery Dissection and ST-Segment Elevation Myocardial Infarction.

Lobo AS, Cantu SM, Sharkey SW, Grey EZ, Storey K, Witt D, Benson G, Garberich RF, Kubota Y, Bairey Merz CN, Henry TD.

J Am Coll Cardiol. 2019 Sep 10;74(10):1290-1300. doi: 10.1016/j.jacc.2019.06.065.

PMID:
31488265
3.

Computed Tomographic Angiography-Derived Risk Factors for Vascular Complications in Percutaneous Transfemoral Transcatheter Aortic Valve Implantation.

Urbach J, Hou CR, Lesser JR, Stanberry LI, Garberich RF, Caye D, Sorajja P, Gössl M.

Am J Cardiol. 2019 Jul 1;124(1):98-104. doi: 10.1016/j.amjcard.2019.03.043. Epub 2019 Apr 10.

PMID:
31029410
4.
5.

A systematic approach for successful PCSK9 inhibitor prescribing in clinical practice.

Knickelbine T, Jia L, White SK, Garberich RF, Oberembt SJ, Wills S, Miedema MD, Brilakis ES.

J Clin Lipidol. 2019 Mar - Apr;13(2):265-271. doi: 10.1016/j.jacl.2019.01.005. Epub 2019 Jan 16.

PMID:
30745203
6.

Clinical and pathologic findings of aortic dissection at autopsy: Review of 336 cases over nearly 6 decades.

Huynh N, Thordsen S, Thomas T, Mackey-Bojack SM, Duncanson ER, Nwuado D, Garberich RF, Harris KM.

Am Heart J. 2019 Mar;209:108-115. doi: 10.1016/j.ahj.2018.11.006. Epub 2018 Nov 22.

PMID:
30660330
7.

NHLBI-Sponsored Randomized Trial of Postconditioning During Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction.

Traverse JH, Swingen CM, Henry TD, Fox J, Wang YL, Chavez IJ, Lips DL, Lesser JR, Pedersen WR, Burke NM, Pai A, Lindberg JL, Garberich RF.

Circ Res. 2019 Mar;124(5):769-778. doi: 10.1161/CIRCRESAHA.118.314060.

PMID:
30602360
8.

Revascularization in "no option" patients with refractory angina: Frequency, etiology and outcomes.

Sharma R, Tradewell M, Kohl LP, Garberich RF, Traverse JH, Poulose A, Brilakis ES, Arndt T, Henry TD.

Catheter Cardiovasc Interv. 2018 Dec 1;92(7):1215-1219. doi: 10.1002/ccd.27707. Epub 2018 Aug 5.

PMID:
30079551
9.

Resource utilization and outcome among patients with selective versus nonselective troponin testing.

Campbell AR, Rodriguez AJ, Larson DM, Strauss CE, Garberich RF, Partridge MF, Henry TD, Sharkey SW.

Am Heart J. 2018 May;199:68-74. doi: 10.1016/j.ahj.2018.01.010. Epub 2018 Jan 31.

PMID:
29754668
10.

In-Hospital ST-Segment Elevation Myocardial Infarction: Improving Diagnosis, Triage, and Treatment.

Levine GN, Dai X, Henry TD, Calfon Press M, Denktas AE, Garberich RF, Jacobs AK, Jaski BE, Kaul P, Kontos MC, Stouffer GA, Smith SC Jr; In-Hospital STEMI Quality Improvement Project.

JAMA Cardiol. 2018 Jun 1;3(6):527-531. doi: 10.1001/jamacardio.2017.5356. Review.

PMID:
29466558
11.

Evaluation of Systemic Heparin Versus Bivalirudin in Adult Patients Supported by Extracorporeal Membrane Oxygenation.

Berei TJ, Lillyblad MP, Wilson KJ, Garberich RF, Hryniewicz KM.

ASAIO J. 2018 Sep/Oct;64(5):623-629. doi: 10.1097/MAT.0000000000000691.

PMID:
29076942
12.

New or presumed new left bundle branch block in patients with suspected ST-elevation myocardial infarction.

Pera VK, Larson DM, Sharkey SW, Garberich RF, Solie CJ, Wang YL, Traverse JH, Poulose AK, Henry TD.

Eur Heart J Acute Cardiovasc Care. 2018 Apr;7(3):208-217. doi: 10.1177/2048872617691508. Epub 2017 Feb 1.

PMID:
29064258
13.

Death and Cardiac Arrest in U.S. Triathlon Participants, 1985 to 2016: A Case Series.

Harris KM, Creswell LL, Haas TS, Thomas T, Tung M, Isaacson E, Garberich RF, Maron BJ.

Ann Intern Med. 2017 Oct 17;167(8):529-535. doi: 10.7326/M17-0847. Epub 2017 Sep 19.

PMID:
28975231
14.

Cardiovascular CT for evaluation of single-ventricle heart disease: risks and accuracy compared with interventional findings.

Han BK, Huntley M, Overman D, Witt D, Dassenko D, Garberich RF, Lesser JR.

Cardiol Young. 2018 Jan;28(1):9-20. doi: 10.1017/S1047951117001135. Epub 2017 Sep 11.

PMID:
28889811
15.

Sex-based differences in quality of care and outcomes in a health system using a standardized STEMI protocol.

Wei J, Mehta PK, Grey E, Garberich RF, Hauser R, Bairey Merz CN, Henry TD.

Am Heart J. 2017 Sep;191:30-36. doi: 10.1016/j.ahj.2017.06.005. Epub 2017 Jun 17.

16.

Association of Guideline Adherence for Serial Evaluations With Survival and Adverse Clinical Events in Patients With Asymptomatic Severe Aortic Stenosis.

Ahmed A, Sorajja P, Garberich RF, Farivar RS, Harris KM, Gössl M.

JAMA Cardiol. 2017 Oct 1;2(10):1141-1146. doi: 10.1001/jamacardio.2017.2952.

17.

Diagnosis, Management, and Outcome of Aortitis at a Single Center.

Skeik N, Ostertag-Hill CA, Garberich RF, Alden PB, Alexander JQ, Cragg AH, Manunga JM, Stephenson EJ, Titus JM, Sullivan TM.

Vasc Endovascular Surg. 2017 Oct;51(7):470-479. doi: 10.1177/1538574417704296. Epub 2017 Aug 31. Review.

PMID:
28859604
18.

Fifty Men, 3510 Marathons, Cardiac Risk Factors, and Coronary Artery Calcium Scores.

Roberts WO, Schwartz RS, Garberich RF, Carlson S, Knickelbine T, Schwartz JG, Peichel G, Lesser JR, Wickstrom K, Harris KM.

Med Sci Sports Exerc. 2017 Dec;49(12):2369-2373. doi: 10.1249/MSS.0000000000001373.

PMID:
28719492
19.

In-Hospital ST Elevation Myocardial Infarction: Clinical Characteristics, Management Challenges, and Outcome.

Dai X, Garberich RF, Jaski BE, Smith SC Jr, Henry TD.

Interv Cardiol Clin. 2016 Oct;5(4):471-480. doi: 10.1016/j.iccl.2016.06.005. Epub 2016 Aug 5. Review.

PMID:
28581996
20.

Statin Eligibility and Outpatient Care Prior to ST-Segment Elevation Myocardial Infarction.

Miedema MD, Garberich RF, Schnaidt LJ, Peterson E, Strauss C, Sharkey S, Knickelbine T, Newell MC, Henry TD.

J Am Heart Assoc. 2017 Apr 12;6(4). pii: e005333. doi: 10.1161/JAHA.116.005333.

21.

Hypertrophic Cardiomyopathy With Left Ventricular Apical Aneurysm: Implications for Risk Stratification and Management.

Rowin EJ, Maron BJ, Haas TS, Garberich RF, Wang W, Link MS, Maron MS.

J Am Coll Cardiol. 2017 Feb 21;69(7):761-773. doi: 10.1016/j.jacc.2016.11.063. Erratum in: J Am Coll Cardiol. 2017 Mar 28;69(12):1652.

22.

Long-Term Marathon Running Is Associated with Low Coronary Plaque Formation in Women.

Roberts WO, Schwartz RS, Kraus SM, Schwartz JG, Peichel G, Garberich RF, Lesser JR, Oesterle SN, Wickstrom KK, Knickelbine T, Harris KM.

Med Sci Sports Exerc. 2017 Apr;49(4):641-645. doi: 10.1249/MSS.0000000000001154.

PMID:
27824692
23.

Demographics and Epidemiology of Sudden Deaths in Young Competitive Athletes: From the United States National Registry.

Maron BJ, Haas TS, Ahluwalia A, Murphy CJ, Garberich RF.

Am J Med. 2016 Nov;129(11):1170-1177. doi: 10.1016/j.amjmed.2016.02.031. Epub 2016 Apr 1.

PMID:
27039955
24.

Time in Therapeutic Range for Left Ventricular Assist Device Patients Anticoagulated With Warfarin: A Correlation to Clinical Outcomes.

Halder LC, Richardson LB, Garberich RF, Zimbwa P, Bennett MK.

ASAIO J. 2017 Jan/Feb;63(1):37-40. doi: 10.1097/MAT.0000000000000449.

PMID:
27676409
25.

Design, Challenges, and Implications of Quality Improvement Projects Using the Electronic Medical Record: Case Study: A Protocol to Reduce the Burden of Postoperative Atrial Fibrillation.

Ebinger JE, Porten BR, Strauss CE, Garberich RF, Han C, Wahl SK, Sun BC, Abdelhadi RH, Henry TD.

Circ Cardiovasc Qual Outcomes. 2016 Sep;9(5):593-9. doi: 10.1161/CIRCOUTCOMES.116.003122. Epub 2016 Aug 23.

26.

Accessory renal arteries: Prevalence in resistant hypertension and an important role in nonresponse to radiofrequency renal denervation.

VonAchen P, Hamann J, Houghland T, Lesser JR, Wang Y, Caye D, Rosenthal K, Garberich RF, Daniels M, Schwartz RS.

Cardiovasc Revasc Med. 2016 Oct - Nov;17(7):470-473. doi: 10.1016/j.carrev.2016.07.009. Epub 2016 Jul 21.

PMID:
27493150
27.

Relation of Doppler Tissue Imaging Parameters With Heart Failure Progression in Hypertrophic Cardiomyopathy.

Kalra A, Harris KM, Maron BA, Maron MS, Garberich RF, Haas TS, Lesser JR, Maron BJ.

Am J Cardiol. 2016 Jun 1;117(11):1808-14. doi: 10.1016/j.amjcard.2016.03.018. Epub 2016 Mar 19.

PMID:
27089980
28.

Contemporary Natural History and Management of Nonobstructive Hypertrophic Cardiomyopathy.

Maron MS, Rowin EJ, Olivotto I, Casey SA, Arretini A, Tomberli B, Garberich RF, Link MS, Chan RHM, Lesser JR, Maron BJ.

J Am Coll Cardiol. 2016 Mar 29;67(12):1399-1409. doi: 10.1016/j.jacc.2016.01.023.

29.

Comparison of the Frequency of Sudden Cardiovascular Deaths in Young Competitive Athletes Versus Nonathletes: Should We Really Screen Only Athletes?

Maron BJ, Haas TS, Duncanson ER, Garberich RF, Baker AM, Mackey-Bojack S.

Am J Cardiol. 2016 Apr 15;117(8):1339-41. doi: 10.1016/j.amjcard.2016.01.026. Epub 2016 Feb 1.

PMID:
26949036
30.

What Do Patients With Hypertrophic Cardiomyopathy Die from?

Maron BJ, Rowin EJ, Casey SA, Garberich RF, Maron MS.

Am J Cardiol. 2016 Feb 1;117(3):434-5. doi: 10.1016/j.amjcard.2015.11.013. Epub 2015 Nov 18. Review.

PMID:
26718233
31.

Eligibility and utilization of implantable cardioverter-defibrillators in a regional STEMI system.

Johnson BK, Garberich RF, Henry TD, Katsiyiannis WT, Sengupta J, Kalra A, Hauser RG, Lardy ME, Newell MC.

Heart Rhythm. 2016 Feb;13(2):538-46. doi: 10.1016/j.hrthm.2015.10.019. Epub 2015 Oct 13.

PMID:
26576706
32.

Hypertrophic Cardiomyopathy in Children, Adolescents, and Young Adults Associated With Low Cardiovascular Mortality With Contemporary Management Strategies.

Maron BJ, Rowin EJ, Casey SA, Lesser JR, Garberich RF, McGriff DM, Maron MS.

Circulation. 2016 Jan 5;133(1):62-73. doi: 10.1161/CIRCULATIONAHA.115.017633. Epub 2015 Oct 30.

PMID:
26518766
33.

Multi-institutional evaluation of the indications and radiation dose of functional cardiovascular computed tomography (CCT) imaging in congenital heart disease.

Han BK, Hlavacek AM, Kay WA, Pham TDN, Grant K, Garberich RF, Lesser JR, Raman SV.

Int J Cardiovasc Imaging. 2016 Feb;32(2):339-346. doi: 10.1007/s10554-015-0775-y. Epub 2015 Oct 16.

PMID:
26474570
34.

Arterial Embolisms and Thrombosis in Upper Extremity Ischemia.

Skeik N, Soo-Hoo SS, Porten BR, Graber J, Alden P, Cragg A, Alexander JQ, Rizvi A, Manunga JM Jr, Garberich RF, Sullivan T.

Vasc Endovascular Surg. 2015 Jul-Aug;49(5-6):100-9. doi: 10.1177/1538574415596740.

PMID:
26377187
35.

Independent Assessment of the European Society of Cardiology Sudden Death Risk Model for Hypertrophic Cardiomyopathy.

Maron BJ, Casey SA, Chan RH, Garberich RF, Rowin EJ, Maron MS.

Am J Cardiol. 2015 Sep 1;116(5):757-64. doi: 10.1016/j.amjcard.2015.05.047. Epub 2015 Jun 4.

PMID:
26183790
36.

Clinical Profile of Patients With High-Risk Tako-Tsubo Cardiomyopathy.

Sharkey SW, Pink VR, Lesser JR, Garberich RF, Maron MS, Maron BJ.

Am J Cardiol. 2015 Sep 1;116(5):765-72. doi: 10.1016/j.amjcard.2015.05.054. Epub 2015 Jun 4.

PMID:
26144453
37.

Pathogenic structural heart changes in early tricuspid regurgitation.

Nemoto N, Lesser JR, Pedersen WR, Sorajja P, Spinner E, Garberich RF, Vock DM, Schwartz RS.

J Thorac Cardiovasc Surg. 2015 Aug;150(2):323-30. doi: 10.1016/j.jtcvs.2015.05.009. Epub 2015 May 8.

38.

The Left Main Bifurcation Angle and Changes Throughout the Cardiac Cycle: Quantitative Implications for Left Main Bifurcation Stenting and Stents.

Handran CB, Garberich RF, Lesser JR, Henry TD, Gilmore M, Schwartz RB.

J Invasive Cardiol. 2015 Sep;27(9):401-4. Epub 2015 May 15.

39.

Hypertrophic Cardiomyopathy in Adulthood Associated With Low Cardiovascular Mortality With Contemporary Management Strategies.

Maron BJ, Rowin EJ, Casey SA, Link MS, Lesser JR, Chan RH, Garberich RF, Udelson JE, Maron MS.

J Am Coll Cardiol. 2015 May 12;65(18):1915-28. doi: 10.1016/j.jacc.2015.02.061.

40.

Increasing percutaneous coronary interventions for ST-segment elevation myocardial infarction in the United States: progress and opportunity.

Shah RU, Henry TD, Rutten-Ramos S, Garberich RF, Tighiouart M, Bairey Merz CN.

JACC Cardiovasc Interv. 2015 Jan;8(1 Pt B):139-146. doi: 10.1016/j.jcin.2014.07.017. Epub 2014 Oct 30.

41.

Response to letter regarding article, "ST-elevation myocardial infarction diagnosed after hospital admission".

Garberich RF, Traverse JH, Claussen MT, Rodriguez G, Poulose AK, Chavez IJ, Rutten-Ramos S, Hildebrandt DA, Henry TD.

Circulation. 2015 Jan 6;131(1):e7. doi: 10.1161/CIRCULATIONAHA.114.012786. No abstract available.

PMID:
25561481
42.

"No culprit" ST-elevation myocardial infarction: role of cardiac magnetic resonance imaging.

Stark MM, Schwartz RS, Satran D, Lesser JR, Sharkey SW, Garberich RF, Solie CJ, Longe TF, Flygenring BP, Lin D, Larson DM, Henry TD.

Crit Pathw Cardiol. 2014 Dec;13(4):135-40. doi: 10.1097/HPC.0000000000000023.

PMID:
25396289
43.

Real-time decision support to guide percutaneous coronary intervention bleeding avoidance strategies effectively changes practice patterns.

Strauss CE, Porten BR, Chavez IJ, Garberich RF, Chambers JW, Baran KW, Poulose AK, Henry TD.

Circ Cardiovasc Qual Outcomes. 2014 Nov;7(6):960-7. doi: 10.1161/CIRCOUTCOMES.114.001275. Epub 2014 Nov 4. Review. No abstract available.

PMID:
25371541
44.

Hyperbaric oxygen treatment outcome for different indications from a single center.

Skeik N, Porten BR, Isaacson E, Seong J, Klosterman DL, Garberich RF, Alexander JQ, Rizvi A, Manunga JM Jr, Cragg A, Graber J, Alden P, Sullivan T.

Ann Vasc Surg. 2015 Feb;29(2):206-14. doi: 10.1016/j.avsg.2014.07.034. Epub 2014 Oct 13.

PMID:
25308240
45.

Impact of intraoperative transesophageal echocardiography on acute type-A aortic dissection.

Thorsgard ME, Morrissette GJ, Sun B, Eales F, Kshettry V, Flavin T, Tyberg R, Garberich RF, Harris KM.

J Cardiothorac Vasc Anesth. 2014 Oct;28(5):1203-7. doi: 10.1053/j.jvca.2014.05.012.

PMID:
25281039
46.

Outcomes of primary percutaneous coronary intervention in ST-segment elevation myocardial infarction patients with previous coronary bypass surgery.

Kohl LP, Garberich RF, Yang H, Sharkey SW, Burke MN, Lips DL, Hildebrandt DA, Larson DM, Henry TD.

JACC Cardiovasc Interv. 2014 Sep;7(9):981-7. doi: 10.1016/j.jcin.2014.04.010.

47.

Ranolazine refractory angina registry: 1-year results.

Bennett NM, Iyer V, Arndt TL, Garberich RF, Traverse JH, Johnson RK, Poulose AK, Lips A, Morgan JM, Henry TD.

Crit Pathw Cardiol. 2014 Sep;13(3):96-8. doi: 10.1097/HPC.0000000000000022.

PMID:
25062392
48.

Improvement in aortic valve area using a new "hour glass" shaped valvuloplasty balloon compared with standard cylindrical balloons in severe aortic stenosis patients.

Pedersen WR, Mooney MR, Ungs D, Pedersen C, Sorajja P, Poulose AK, Stark RP, Murad B, Garberich RF, Goldenberg E, Schwartz RS.

Minerva Cardioangiol. 2014 Jun;62(3):243-9.

PMID:
24831760
49.

Strategies for assessing the prevalence of cardiovascular sudden deaths in young competitive athletes.

Maron BJ, Murphy CJ, Haas TS, Ahluwalia A, Garberich RF.

Int J Cardiol. 2014 May 15;173(3):369-72. doi: 10.1016/j.ijcard.2014.02.021. Epub 2014 Feb 22.

PMID:
24704402
50.

Satisfaction with emergent transfer for percutaneous coronary interventions on patients with ST-segment-elevation myocardial infarction and their families.

Henry JT, Christiansen E, Garberich RF, Handran CB, Larson DM, Unger BT, Henry TD.

Circ Cardiovasc Qual Outcomes. 2014 Mar;7(2):244-50. doi: 10.1161/CIRCOUTCOMES.113.000641. Epub 2014 Mar 4.

PMID:
24594547

Supplemental Content

Loading ...
Support Center